Otski Injection is a parenteral formulation containing a balanced combination of essential trace elements: Chromium (0.4 mg), Copper (0.4 mg), Manganese (0.1 mg), and Selenium (0.02 mg) per dose. These micronutrients play critical roles in various physiological processes, including enzymatic reactions, antioxidant defense, and metabolic regulation. Chromium is vital for enhancing insulin action and maintaining normal glucose metabolism, making it beneficial in managing conditions related to impaired carbohydrate metabolism. Copper is essential for hematopoiesis, connective tissue formation, and acts as a cofactor for several enzymes involved in oxidative stress mitigation. Manganese contributes to bone formation, amino acid metabolism, and functions as a cofactor for antioxidant enzymes such as superoxide dismutase. Selenium is a key component of glutathione peroxidase, a major antioxidant enzyme that protects cells from oxidative damage and supports immune function. Otski Injection is indicated for the prevention and treatment of trace element deficiencies in patients who are unable to receive adequate nutrition orally or enterally, particularly in critical care settings, malabsorption syndromes, or prolonged parenteral nutrition. Administration should be performed under medical supervision with appropriate monitoring of trace element levels to avoid toxicity. This formulation supports metabolic homeostasis and enhances recovery in deficient states.